These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 8424585)

  • 1. Capillary filtration and ankle edema in patients with venous hypertension: effects of Daflon.
    Cesarone MR; Laurora G; De Sanctis MT; Belcaro G
    Angiology; 1993 Jan; 44(1):57-61. PubMed ID: 8424585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute effects of TTFCA on capillary filtration in severe venous hypertension.
    De Sanctis MT; Incandela L; Cesarone MR; Grimaldi R; Belcaro G; Marelli C
    Panminerva Med; 1994 Jun; 36(2):87-90. PubMed ID: 7831065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HR, 0-(beta-hydroxyethyl)-rutosides, in comparison with diosmin+hesperidin in chronic venous insufficiency and venous microangiopathy: an independent, prospective, comparative registry study.
    Cesarone MR; Belcaro G; Pellegrini L; Ledda A; Di Renzo A; Vinciguerra G; Ricci A; Gizzi G; Ippolito E; Fano F; Dugall M; Acerbi G; Cacchio M
    Angiology; 2005; 56(1):1-8. PubMed ID: 15678250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Capillary filtration and ankle edema in patients with venous hypertension treated with TTFCA.
    Belcaro GV; Rulo A; Grimaldi R
    Angiology; 1990 Jan; 41(1):12-8. PubMed ID: 2305995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. From symptoms to leg edema: efficacy of Daflon 500 mg.
    Nicolaides AN
    Angiology; 2003; 54 Suppl 1():S33-44. PubMed ID: 12934755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of edema and increased capillary filtration in venous hypertension with total triterpenic fraction of Centella asiatica: a clinical, prospective, placebo-controlled, randomized, dose-ranging trial.
    De Sanctis MT; Belcaro G; Incandela L; Cesarone MR; Griffin M; Ippolito E; Cacchio M
    Angiology; 2001 Oct; 52 Suppl 2():S55-9. PubMed ID: 11666125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms in experimental venous valve failure and their modification by Daflon 500 mg.
    Pascarella L; Lulic D; Penn AH; Alsaigh T; Lee J; Shin H; Kapur V; Bergan JJ; Schmid-Schönbein GW
    Eur J Vasc Endovasc Surg; 2008 Jan; 35(1):102-10. PubMed ID: 17890112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advantage of a micronized flavonoidic fraction (Daflon 500 mg) in comparison with a nonmicronized diosmin.
    Amato C
    Angiology; 1994 Jun; 45(6 Pt 2):531-6. PubMed ID: 8203783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5-Year control and treatment of edema and increased capillary filtration in venous hypertension and diabetic microangiopathy using O-(beta-hydroxyethyl)-rutosides: a prospective comparative clinical registry.
    Belcaro G; Cesarone MR; Ledda A; Cacchio M; Ruffini I; Ricci A; Ippolito E; Di Renzo A; Dugall M; Corsi M; Marino Santarelli AR; Grossi MG
    Angiology; 2008; 59 Suppl 1():14S-20S. PubMed ID: 18287163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical benefits of Daflon 500 mg in the most severe stages of chronic venous insufficiency.
    Ramelet AA
    Angiology; 2001 Aug; 52 Suppl 1():S49-56. PubMed ID: 11510597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improvement of capillary permeability in patients with venous hypertension after treatment with TTFCA.
    Belcaro GV; Grimaldi R; Guidi G
    Angiology; 1990 Jul; 41(7):533-40. PubMed ID: 2389834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Controlled studies of Daflon 500 mg in chronic venous insufficiency.
    Geroulakos G; Nicolaides AN
    Angiology; 1994 Jun; 45(6 Pt 2):549-53. PubMed ID: 8203786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Capillary filtration in venous hypertension: evaluation with the vacuum suction chamber device and strain-gauge plethysmography.
    Belcaro G; Rulo A; Cesarone MR; De Sanctis MT; Incandela L; Griffin M; Cacchio M
    Angiology; 2001 Oct; 52 Suppl 2():S39-43. PubMed ID: 11666122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Daflon 500 mg: symptoms and edema clinical update.
    Ramelet AA
    Angiology; 2005; 56 Suppl 1():S25-32. PubMed ID: 16193223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of edema and increased capillary filtration in venous hypertension with HR (Paroven, Venoruton; 0-(beta-hydroxyethyl)-rutosides): a clinical, prospective, placebo-controlled, randomized, dose-ranging trial.
    Cesarone MR; Incandela L; DeSanctis MT; Belcaro G; Griffin M; Ippolito E; Acerbi G
    J Cardiovasc Pharmacol Ther; 2002 Jan; 7 Suppl 1():S21-4. PubMed ID: 12011969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HR (Venoruton1000, Paroven, 0-[beta-hydroxyethyl]-rutosides) vs. Daflon 500 in chronic venous disease and microangiopathy: an independent prospective, controlled, randomized trial.
    Belcaro G; Cesarone MR; Bavera P; Ricci A; Renton S; Leon M; Ippolito E; Dugall M; Acerbi G
    J Cardiovasc Pharmacol Ther; 2002 Jul; 7(3):139-45. PubMed ID: 12232562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are the phlebotonic properties shown in clinical pharmacology predictive of a therapeutic benefit in chronic venous insufficiency? Our experience with Daflon 500 mg.
    Tsouderos Y
    Int Angiol; 1989; 8(4 Suppl):53-9. PubMed ID: 2698902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Pycnogenol and Daflon in treating chronic venous insufficiency: a prospective, controlled study.
    Cesarone MR; Belcaro G; Rohdewald P; Pellegrini L; Ledda A; Vinciguerra G; Ricci A; Gizzi G; Ippolito E; Fano F; Dugall M; Acerbi G; Cacchio M; Di Renzo A; Hosoi M; Stuard S; Corsi M
    Clin Appl Thromb Hemost; 2006 Apr; 12(2):205-12. PubMed ID: 16708123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Venous tone: are the phlebotonic properties predictive of a therapeutic benefit? A comprehensive view of our experience with Daflon 500 mg.
    Tsouderos Y
    Z Kardiol; 1991; 80 Suppl 7():95-101. PubMed ID: 1792820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of hydroxyethylrutosides on capillary filtration in moderate venous hypertension: a double blind study.
    Renton S; Leon M; Belcaro G; Nicolaides AN
    Int Angiol; 1994 Sep; 13(3):259-62. PubMed ID: 7822903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.